

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.86135617 |
| 2 | viral transcription (GO:0019083) | 4.56563851 |
| 3 | formation of translation preinitiation complex (GO:0001731) | 4.51797167 |
| 4 | translational termination (GO:0006415) | 4.45479840 |
| 5 | GDP-mannose metabolic process (GO:0019673) | 4.28812777 |
| 6 | protein maturation by protein folding (GO:0022417) | 4.18532747 |
| 7 | translational elongation (GO:0006414) | 4.13643465 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.90553773 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.90334792 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 3.86782023 |
| 11 | translational initiation (GO:0006413) | 3.86310295 |
| 12 | proline biosynthetic process (GO:0006561) | 3.85669675 |
| 13 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.80725452 |
| 14 | protein targeting to ER (GO:0045047) | 3.77879211 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 3.76054502 |
| 16 | DNA deamination (GO:0045006) | 3.75549573 |
| 17 | DNA strand elongation (GO:0022616) | 3.68194900 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 3.67780128 |
| 19 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.62540065 |
| 20 | viral life cycle (GO:0019058) | 3.59563626 |
| 21 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.59520916 |
| 22 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.55142188 |
| 23 | protein localization to endoplasmic reticulum (GO:0070972) | 3.55131448 |
| 24 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.53641972 |
| 25 | ribosomal small subunit biogenesis (GO:0042274) | 3.53379469 |
| 26 | cellular protein complex disassembly (GO:0043624) | 3.49051343 |
| 27 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.48902645 |
| 28 | establishment of integrated proviral latency (GO:0075713) | 3.47565420 |
| 29 | regulation of mitochondrial translation (GO:0070129) | 3.45327525 |
| 30 | regulation of protein heterodimerization activity (GO:0043497) | 3.41053587 |
| 31 | nucleobase biosynthetic process (GO:0046112) | 3.38281535 |
| 32 | establishment of viral latency (GO:0019043) | 3.35749086 |
| 33 | DNA replication initiation (GO:0006270) | 3.28552199 |
| 34 | protein localization to kinetochore (GO:0034501) | 3.25678737 |
| 35 | ribosomal large subunit biogenesis (GO:0042273) | 3.24025213 |
| 36 | pentose-phosphate shunt (GO:0006098) | 3.22250817 |
| 37 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21401997 |
| 38 | purine nucleobase biosynthetic process (GO:0009113) | 3.16057230 |
| 39 | protein complex disassembly (GO:0043241) | 3.15356663 |
| 40 | histone arginine methylation (GO:0034969) | 3.12091750 |
| 41 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.07857275 |
| 42 | folic acid metabolic process (GO:0046655) | 3.04989836 |
| 43 | mitotic nuclear envelope reassembly (GO:0007084) | 3.04023694 |
| 44 | nuclear envelope reassembly (GO:0031468) | 3.04023694 |
| 45 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.02158970 |
| 46 | pentose metabolic process (GO:0019321) | 3.01990663 |
| 47 | nucleoside salvage (GO:0043174) | 3.01970205 |
| 48 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.00391423 |
| 49 | translation (GO:0006412) | 2.98678518 |
| 50 | telomere maintenance via recombination (GO:0000722) | 2.97687290 |
| 51 | macromolecular complex disassembly (GO:0032984) | 2.96088432 |
| 52 | mitotic nuclear envelope disassembly (GO:0007077) | 2.95842119 |
| 53 | T cell apoptotic process (GO:0070231) | 2.92975165 |
| 54 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.92776356 |
| 55 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.90504743 |
| 56 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.90504743 |
| 57 | viral mRNA export from host cell nucleus (GO:0046784) | 2.89399006 |
| 58 | NADPH regeneration (GO:0006740) | 2.89235957 |
| 59 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.85709996 |
| 60 | IMP biosynthetic process (GO:0006188) | 2.84078866 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.82008627 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.81590452 |
| 63 | peptidyl-arginine methylation (GO:0018216) | 2.80379383 |
| 64 | peptidyl-arginine N-methylation (GO:0035246) | 2.80379383 |
| 65 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.80346596 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.78553329 |
| 67 | DNA replication checkpoint (GO:0000076) | 2.78403949 |
| 68 | protein targeting to mitochondrion (GO:0006626) | 2.77600818 |
| 69 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.76012770 |
| 70 | protein localization to chromosome, centromeric region (GO:0071459) | 2.75410394 |
| 71 | negative regulation of ligase activity (GO:0051352) | 2.74181386 |
| 72 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.74181386 |
| 73 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.73718900 |
| 74 | heterochromatin organization (GO:0070828) | 2.73532629 |
| 75 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.73186168 |
| 76 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.72853334 |
| 77 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.72697669 |
| 78 | membrane disassembly (GO:0030397) | 2.71934388 |
| 79 | nuclear envelope disassembly (GO:0051081) | 2.71934388 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 2.71425084 |
| 81 | mitotic recombination (GO:0006312) | 2.71211980 |
| 82 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.70607820 |
| 83 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.69973658 |
| 84 | rRNA transcription (GO:0009303) | 2.69716832 |
| 85 | ribosome biogenesis (GO:0042254) | 2.69420363 |
| 86 | ribosome assembly (GO:0042255) | 2.69394837 |
| 87 | protein retention in ER lumen (GO:0006621) | 2.68934680 |
| 88 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.68571889 |
| 89 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.66427102 |
| 90 | proteasome assembly (GO:0043248) | 2.66198522 |
| 91 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.65310997 |
| 92 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.65044796 |
| 93 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.63697539 |
| 94 | cellular component biogenesis (GO:0044085) | 2.63430552 |
| 95 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.61633142 |
| 96 | tetrahydrofolate metabolic process (GO:0046653) | 2.61504948 |
| 97 | telomere maintenance via telomere lengthening (GO:0010833) | 2.60895764 |
| 98 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.60148488 |
| 99 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.59424495 |
| 100 | maternal placenta development (GO:0001893) | 2.59214407 |
| 101 | UTP biosynthetic process (GO:0006228) | 2.58913822 |
| 102 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.58318546 |
| 103 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.57975180 |
| 104 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.57360189 |
| 105 | establishment of protein localization to mitochondrion (GO:0072655) | 2.56801252 |
| 106 | pseudouridine synthesis (GO:0001522) | 2.55685231 |
| 107 | NADH metabolic process (GO:0006734) | 2.54321854 |
| 108 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.54176906 |
| 109 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.54176906 |
| 110 | glucose catabolic process (GO:0006007) | 2.53478018 |
| 111 | protein targeting to membrane (GO:0006612) | 2.53470333 |
| 112 | COPI coating of Golgi vesicle (GO:0048205) | 2.52018031 |
| 113 | Golgi transport vesicle coating (GO:0048200) | 2.52018031 |
| 114 | oxidative phosphorylation (GO:0006119) | 2.51489404 |
| 115 | spliceosomal snRNP assembly (GO:0000387) | 2.51409156 |
| 116 | mitochondrial fusion (GO:0008053) | 2.50812493 |
| 117 | chaperone-mediated protein transport (GO:0072321) | 2.50024893 |
| 118 | mRNA catabolic process (GO:0006402) | 2.49808147 |
| 119 | regulation of superoxide anion generation (GO:0032928) | 2.49489942 |
| 120 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.49451330 |
| 121 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.49451330 |
| 122 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.49451330 |
| 123 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.49065568 |
| 124 | lymphocyte apoptotic process (GO:0070227) | 2.49005078 |
| 125 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.48930510 |
| 126 | RNA catabolic process (GO:0006401) | 2.47497120 |
| 127 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.46640084 |
| 128 | IMP metabolic process (GO:0046040) | 2.46373401 |
| 129 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.45648602 |
| 130 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.45648602 |
| 131 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.45467030 |
| 132 | mitotic metaphase plate congression (GO:0007080) | 2.44103062 |
| 133 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.44029539 |
| 134 | rRNA processing (GO:0006364) | 2.43868525 |
| 135 | cell cycle G1/S phase transition (GO:0044843) | 2.42796959 |
| 136 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.42796959 |
| 137 | regulation of translational fidelity (GO:0006450) | 2.42744247 |
| 138 | galactose catabolic process (GO:0019388) | 2.42289049 |
| 139 | regulation of translational termination (GO:0006449) | 2.41779904 |
| 140 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.39679515 |
| 141 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.39173644 |
| 142 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.39173644 |
| 143 | positive regulation of ligase activity (GO:0051351) | 2.35389320 |
| 144 | glycine metabolic process (GO:0006544) | 2.34856239 |
| 145 | folic acid-containing compound metabolic process (GO:0006760) | 2.34467317 |
| 146 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.33990191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.50519334 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.12201494 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.58704747 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.85816366 |
| 5 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.46808213 |
| 6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.46029265 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34812013 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27088123 |
| 9 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.25060560 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.21842546 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20726718 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.20119284 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18926788 |
| 14 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.17926039 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.16479954 |
| 16 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.13492403 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.12824557 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.06848944 |
| 19 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.97411623 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.90294017 |
| 21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82526735 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82156918 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80869038 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79210636 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74330016 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73203165 |
| 27 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69065072 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.66123474 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.65714463 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64832446 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.64145199 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64118863 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63211967 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61554506 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59014963 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50721860 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.50577596 |
| 38 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.48717642 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48659690 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48348722 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47704624 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47207901 |
| 43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44392738 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43701727 |
| 45 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43178783 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42081336 |
| 47 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40874026 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39958677 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39408506 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35751240 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34643785 |
| 52 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34111903 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33893265 |
| 54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.33056278 |
| 55 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30674384 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30360175 |
| 57 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29784071 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29775506 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28694201 |
| 60 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28618206 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28149572 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27962085 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25488865 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24342061 |
| 65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.23908921 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23181216 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22860768 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22671495 |
| 69 | * SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22451728 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21224022 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19782128 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19195536 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18761146 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17499444 |
| 75 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17170998 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15827045 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15331435 |
| 78 | P68_20966046_ChIP-Seq_HELA_Human | 1.15322857 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15202096 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14437421 |
| 81 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14035918 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13555029 |
| 83 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13271460 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.13234819 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11838548 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11696720 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11132423 |
| 88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10533287 |
| 89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09736559 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09573453 |
| 91 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09194517 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08917989 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08654740 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08095634 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 1.07695549 |
| 96 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07691919 |
| 97 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07151263 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06844996 |
| 99 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06298262 |
| 100 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05909568 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05768521 |
| 102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05156932 |
| 103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04747903 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04390790 |
| 105 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03287576 |
| 106 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02976184 |
| 107 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.02898224 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02671861 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02045591 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00354719 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00252395 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99787136 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99698281 |
| 114 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99296302 |
| 115 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99060671 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98652030 |
| 117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96450551 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95587663 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94811534 |
| 120 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94007412 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93785169 |
| 122 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93780500 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93353395 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92975184 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92299793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.70654924 |
| 2 | MP0005451_abnormal_body_composition | 3.16680112 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 2.88588326 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 2.81830170 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.77741921 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.69759725 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.43104395 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.41924120 |
| 9 | MP0003077_abnormal_cell_cycle | 2.32976472 |
| 10 | MP0008260_abnormal_autophagy | 2.25637126 |
| 11 | MP0009840_abnormal_foam_cell | 2.06192114 |
| 12 | MP0003436_decreased_susceptibility_to | 1.97878147 |
| 13 | MP0010094_abnormal_chromosome_stability | 1.95327978 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 1.95270508 |
| 15 | MP0000490_abnormal_crypts_of | 1.94714449 |
| 16 | MP0006054_spinal_hemorrhage | 1.92155863 |
| 17 | MP0005501_abnormal_skin_physiology | 1.89890822 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 1.80983368 |
| 19 | MP0002796_impaired_skin_barrier | 1.77432436 |
| 20 | MP0005360_urolithiasis | 1.76750808 |
| 21 | MP0003186_abnormal_redox_activity | 1.72413686 |
| 22 | MP0008007_abnormal_cellular_replicative | 1.71300851 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.71052243 |
| 24 | MP0004858_abnormal_nervous_system | 1.69013354 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.67458553 |
| 26 | MP0001730_embryonic_growth_arrest | 1.63881118 |
| 27 | MP0005023_abnormal_wound_healing | 1.63085069 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.61815352 |
| 29 | MP0000858_altered_metastatic_potential | 1.61443300 |
| 30 | MP0008932_abnormal_embryonic_tissue | 1.56314246 |
| 31 | MP0010307_abnormal_tumor_latency | 1.53543539 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.48904219 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.43691972 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.43691972 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.43527540 |
| 36 | MP0009379_abnormal_foot_pigmentation | 1.42396027 |
| 37 | MP0003786_premature_aging | 1.39648168 |
| 38 | MP0009785_altered_susceptibility_to | 1.37827009 |
| 39 | MP0004233_abnormal_muscle_weight | 1.37477270 |
| 40 | MP0000685_abnormal_immune_system | 1.37346069 |
| 41 | MP0000350_abnormal_cell_proliferation | 1.36245798 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.35651177 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.32114575 |
| 44 | MP0003123_paternal_imprinting | 1.31329233 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.28251536 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.25024930 |
| 47 | MP0002019_abnormal_tumor_incidence | 1.24727988 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.20773174 |
| 49 | MP0002722_abnormal_immune_system | 1.18709107 |
| 50 | MP0005025_abnormal_response_to | 1.18155313 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.17711883 |
| 52 | MP0001853_heart_inflammation | 1.17505459 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.17368216 |
| 54 | MP0001849_ear_inflammation | 1.16907309 |
| 55 | MP0002405_respiratory_system_inflammati | 1.16286149 |
| 56 | MP0002398_abnormal_bone_marrow | 1.15925931 |
| 57 | MP0001697_abnormal_embryo_size | 1.15695221 |
| 58 | MP0003303_peritoneal_inflammation | 1.15002169 |
| 59 | MP0002080_prenatal_lethality | 1.12976388 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.11923987 |
| 61 | MP0009053_abnormal_anal_canal | 1.11289293 |
| 62 | MP0001881_abnormal_mammary_gland | 1.09428732 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.09089340 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.08746529 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.07644632 |
| 66 | MP0001727_abnormal_embryo_implantation | 1.05626072 |
| 67 | MP0000313_abnormal_cell_death | 1.05177514 |
| 68 | MP0003315_abnormal_perineum_morphology | 1.04906677 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.04369535 |
| 70 | MP0002429_abnormal_blood_cell | 1.04170876 |
| 71 | MP0002086_abnormal_extraembryonic_tissu | 1.03621819 |
| 72 | MP0005000_abnormal_immune_tolerance | 1.02727796 |
| 73 | MP0008058_abnormal_DNA_repair | 1.02677631 |
| 74 | MP0001800_abnormal_humoral_immune | 1.02098119 |
| 75 | MP0001672_abnormal_embryogenesis/_devel | 1.01372843 |
| 76 | MP0005380_embryogenesis_phenotype | 1.01372843 |
| 77 | MP0003984_embryonic_growth_retardation | 1.00869104 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.00743321 |
| 79 | MP0001216_abnormal_epidermal_layer | 0.99128480 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 0.99078395 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.98796627 |
| 82 | MP0000477_abnormal_intestine_morphology | 0.98582693 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.98537764 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 0.98340595 |
| 85 | MP0009278_abnormal_bone_marrow | 0.98095973 |
| 86 | MP0000598_abnormal_liver_morphology | 0.97951139 |
| 87 | MP0001819_abnormal_immune_cell | 0.97327663 |
| 88 | MP0002420_abnormal_adaptive_immunity | 0.96630099 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.95687338 |
| 90 | MP0008057_abnormal_DNA_replication | 0.95592828 |
| 91 | MP0005623_abnormal_meninges_morphology | 0.95446729 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 0.95162435 |
| 93 | MP0002163_abnormal_gland_morphology | 0.94586794 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.94506661 |
| 95 | MP0000716_abnormal_immune_system | 0.94107206 |
| 96 | MP0002419_abnormal_innate_immunity | 0.93927071 |
| 97 | MP0000537_abnormal_urethra_morphology | 0.93528233 |
| 98 | MP0003866_abnormal_defecation | 0.93311679 |
| 99 | MP0004197_abnormal_fetal_growth/weight/ | 0.93203130 |
| 100 | MP0004947_skin_inflammation | 0.93063752 |
| 101 | MP0003448_altered_tumor_morphology | 0.92984506 |
| 102 | MP0000358_abnormal_cell_content/ | 0.91636658 |
| 103 | MP0001661_extended_life_span | 0.90968809 |
| 104 | MP0002723_abnormal_immune_serum | 0.90882157 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90807550 |
| 106 | MP0003075_altered_response_to | 0.90755625 |
| 107 | MP0003279_aneurysm | 0.90247782 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.90016250 |
| 109 | MP0003191_abnormal_cellular_cholesterol | 0.86475101 |
| 110 | MP0005275_abnormal_skin_tensile | 0.86169061 |
| 111 | MP0008469_abnormal_protein_level | 0.85874644 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85523222 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.85117077 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.84553997 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.83987540 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.83131225 |
| 117 | MP0005083_abnormal_biliary_tract | 0.82750977 |
| 118 | MP0006082_CNS_inflammation | 0.82677678 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.81562986 |
| 120 | MP0001346_abnormal_lacrimal_gland | 0.81133975 |
| 121 | MP0000343_altered_response_to | 0.80857738 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.80347709 |
| 123 | MP0001790_abnormal_immune_system | 0.80320481 |
| 124 | MP0005671_abnormal_response_to | 0.80260162 |
| 125 | MP0002132_abnormal_respiratory_system | 0.80057228 |
| 126 | MP0001915_intracranial_hemorrhage | 0.79924753 |
| 127 | MP0002085_abnormal_embryonic_tissue | 0.78388044 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.78386581 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.77456827 |
| 130 | MP0001873_stomach_inflammation | 0.76289579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.84639293 |
| 2 | Reticulocytopenia (HP:0001896) | 3.78469380 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 3.57346632 |
| 4 | Ragged-red muscle fibers (HP:0003200) | 3.42389043 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.28454121 |
| 6 | Multiple enchondromatosis (HP:0005701) | 3.21753706 |
| 7 | Microvesicular hepatic steatosis (HP:0001414) | 3.21454600 |
| 8 | Progressive muscle weakness (HP:0003323) | 3.08803688 |
| 9 | Thrombocytosis (HP:0001894) | 2.99120827 |
| 10 | Trismus (HP:0000211) | 2.95420047 |
| 11 | Abnormality of the anterior horn cell (HP:0006802) | 2.82550047 |
| 12 | Degeneration of anterior horn cells (HP:0002398) | 2.82550047 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78682113 |
| 14 | Oral leukoplakia (HP:0002745) | 2.72485242 |
| 15 | Macrocytic anemia (HP:0001972) | 2.69853084 |
| 16 | Microretrognathia (HP:0000308) | 2.66710067 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 2.64174987 |
| 18 | Hypertensive crisis (HP:0100735) | 2.62089082 |
| 19 | Selective tooth agenesis (HP:0001592) | 2.58682148 |
| 20 | Increased muscle lipid content (HP:0009058) | 2.57843073 |
| 21 | Abnormality of the umbilical cord (HP:0010881) | 2.56489753 |
| 22 | Pallor (HP:0000980) | 2.52318169 |
| 23 | Petechiae (HP:0000967) | 2.49739028 |
| 24 | Testicular atrophy (HP:0000029) | 2.48883816 |
| 25 | Vertebral compression fractures (HP:0002953) | 2.48095913 |
| 26 | Achilles tendon contracture (HP:0001771) | 2.40688378 |
| 27 | Obstructive lung disease (HP:0006536) | 2.37370346 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37370346 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.37019242 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.35400966 |
| 31 | Spastic diplegia (HP:0001264) | 2.35174091 |
| 32 | Cervical subluxation (HP:0003308) | 2.34838751 |
| 33 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.31653038 |
| 34 | Single umbilical artery (HP:0001195) | 2.31653038 |
| 35 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.31653038 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28743561 |
| 37 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.26544358 |
| 38 | Poor head control (HP:0002421) | 2.25821902 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.25409763 |
| 40 | Cholecystitis (HP:0001082) | 2.25409763 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.24348381 |
| 42 | Abnormality of reticulocytes (HP:0004312) | 2.24294193 |
| 43 | Rough bone trabeculation (HP:0100670) | 2.23238702 |
| 44 | Aplastic anemia (HP:0001915) | 2.22702965 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.22382065 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.20938871 |
| 47 | Broad distal phalanx of finger (HP:0009836) | 2.17871175 |
| 48 | Hypokinesia (HP:0002375) | 2.13864672 |
| 49 | Hepatocellular necrosis (HP:0001404) | 2.13139162 |
| 50 | Birth length less than 3rd percentile (HP:0003561) | 2.12664033 |
| 51 | Abnormality of the Achilles tendon (HP:0005109) | 2.11888969 |
| 52 | Peritonitis (HP:0002586) | 2.11654164 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.10628513 |
| 54 | Breast hypoplasia (HP:0003187) | 2.09916212 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.07028981 |
| 56 | Pustule (HP:0200039) | 2.04511723 |
| 57 | Nausea (HP:0002018) | 2.02979237 |
| 58 | Increased serum ferritin (HP:0003281) | 2.02685014 |
| 59 | Fasciculations (HP:0002380) | 2.01571483 |
| 60 | Nonimmune hydrops fetalis (HP:0001790) | 2.01459879 |
| 61 | Carpal bone hypoplasia (HP:0001498) | 2.01376914 |
| 62 | Mitochondrial inheritance (HP:0001427) | 1.99018888 |
| 63 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.97802601 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 1.97515639 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96567872 |
| 66 | Increased serum lactate (HP:0002151) | 1.96312957 |
| 67 | Colon cancer (HP:0003003) | 1.96122410 |
| 68 | Seborrheic dermatitis (HP:0001051) | 1.95215237 |
| 69 | Biconcave vertebral bodies (HP:0004586) | 1.94748995 |
| 70 | Premature ovarian failure (HP:0008209) | 1.94590755 |
| 71 | Abnormal cartilage morphology (HP:0002763) | 1.93080556 |
| 72 | Lactic acidosis (HP:0003128) | 1.91077309 |
| 73 | Hyperacusis (HP:0010780) | 1.90724003 |
| 74 | Pancytopenia (HP:0001876) | 1.89767903 |
| 75 | Adenoma sebaceum (HP:0009720) | 1.89627750 |
| 76 | Angiofibromas (HP:0010615) | 1.89627750 |
| 77 | Hepatic necrosis (HP:0002605) | 1.87995679 |
| 78 | IgM deficiency (HP:0002850) | 1.87727258 |
| 79 | Hand muscle atrophy (HP:0009130) | 1.86221875 |
| 80 | Increased IgM level (HP:0003496) | 1.85389281 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 1.83996526 |
| 82 | Increased CSF lactate (HP:0002490) | 1.83124678 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 1.83035314 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 1.82966741 |
| 85 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82324755 |
| 86 | Recurrent abscess formation (HP:0002722) | 1.81870365 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81719993 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81719993 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81719993 |
| 90 | Acute encephalopathy (HP:0006846) | 1.80528349 |
| 91 | Squamous cell carcinoma (HP:0002860) | 1.80058038 |
| 92 | Hyperparathyroidism (HP:0000843) | 1.79907422 |
| 93 | Neoplasm of the pancreas (HP:0002894) | 1.79511199 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78940141 |
| 95 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78239776 |
| 96 | Exercise intolerance (HP:0003546) | 1.77538426 |
| 97 | Death in infancy (HP:0001522) | 1.77522312 |
| 98 | Orthostatic hypotension (HP:0001278) | 1.77511821 |
| 99 | Myositis (HP:0100614) | 1.77166096 |
| 100 | Progressive neurologic deterioration (HP:0002344) | 1.77092506 |
| 101 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.75185007 |
| 102 | Secondary amenorrhea (HP:0000869) | 1.74699516 |
| 103 | Abnormality of macrophages (HP:0004311) | 1.74528957 |
| 104 | Beaking of vertebral bodies (HP:0004568) | 1.74210158 |
| 105 | Agnosia (HP:0010524) | 1.73899446 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.72673837 |
| 107 | Increased hepatocellular lipid droplets (HP:0006565) | 1.72317547 |
| 108 | Abnormal platelet function (HP:0011869) | 1.71150380 |
| 109 | Impaired platelet aggregation (HP:0003540) | 1.71150380 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.70914993 |
| 111 | Ankle contracture (HP:0006466) | 1.70756730 |
| 112 | Premature rupture of membranes (HP:0001788) | 1.70658269 |
| 113 | Increased density of long bones (HP:0006392) | 1.69141675 |
| 114 | Lipid accumulation in hepatocytes (HP:0006561) | 1.69034312 |
| 115 | Slender long bone (HP:0003100) | 1.68603535 |
| 116 | Sparse eyelashes (HP:0000653) | 1.67148538 |
| 117 | Urticaria (HP:0001025) | 1.67033549 |
| 118 | Respiratory difficulties (HP:0002880) | 1.66374384 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 1.66291274 |
| 120 | Septate vagina (HP:0001153) | 1.66086041 |
| 121 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65887864 |
| 122 | Neoplasm of head and neck (HP:0012288) | 1.65605502 |
| 123 | Esophageal neoplasm (HP:0100751) | 1.65605502 |
| 124 | Basal cell carcinoma (HP:0002671) | 1.65430480 |
| 125 | Abnormality of T cell physiology (HP:0011840) | 1.64845952 |
| 126 | Hypobetalipoproteinemia (HP:0003563) | 1.64702019 |
| 127 | Entropion (HP:0000621) | 1.64675219 |
| 128 | Hypergonadotropic hypogonadism (HP:0000815) | 1.64395970 |
| 129 | Polygenic inheritance (HP:0010982) | 1.64118967 |
| 130 | Abnormality of the acetabulum (HP:0003170) | 1.63923475 |
| 131 | Renal Fanconi syndrome (HP:0001994) | 1.63197353 |
| 132 | Acute hepatic failure (HP:0006554) | 1.62896930 |
| 133 | Cerebral edema (HP:0002181) | 1.62038986 |
| 134 | Abnormality of the tricuspid valve (HP:0001702) | 1.61867166 |
| 135 | Hyperammonemia (HP:0001987) | 1.60987424 |
| 136 | Cellulitis (HP:0100658) | 1.60824135 |
| 137 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.59879612 |
| 138 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.59413411 |
| 139 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.59413411 |
| 140 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.58987183 |
| 141 | Spastic paraparesis (HP:0002313) | 1.58942999 |
| 142 | Gastrointestinal dysmotility (HP:0002579) | 1.58840533 |
| 143 | Recurrent bacterial skin infections (HP:0005406) | 1.58318041 |
| 144 | Personality changes (HP:0000751) | 1.56831537 |
| 145 | Megaloblastic anemia (HP:0001889) | 1.56342076 |
| 146 | Genu recurvatum (HP:0002816) | 1.56012063 |
| 147 | Glossoptosis (HP:0000162) | 1.55713544 |
| 148 | Abnormal trabecular bone morphology (HP:0100671) | 1.55149360 |
| 149 | Reduced antithrombin III activity (HP:0001976) | 1.55068436 |
| 150 | Micronodular cirrhosis (HP:0001413) | 1.54404666 |
| 151 | Abnormality of the calcaneus (HP:0008364) | 1.53480740 |
| 152 | Ileus (HP:0002595) | 1.53427431 |
| 153 | Patellar aplasia (HP:0006443) | 1.53068797 |
| 154 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.52632395 |
| 155 | Deviation of the thumb (HP:0009603) | 1.52239111 |
| 156 | Mesangial abnormality (HP:0001966) | 1.51784283 |
| 157 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.48608040 |
| 158 | Chondrocalcinosis (HP:0000934) | 1.48542007 |
| 159 | Abnormality of T cells (HP:0002843) | 1.47580515 |
| 160 | Malnutrition (HP:0004395) | 1.47343346 |
| 161 | Cutaneous melanoma (HP:0012056) | 1.47233765 |
| 162 | Abnormal neuron morphology (HP:0012757) | 1.46960490 |
| 163 | Abnormality of the motor neurons (HP:0002450) | 1.46960490 |
| 164 | Tongue fasciculations (HP:0001308) | 1.44558521 |
| 165 | Premature graying of hair (HP:0002216) | 1.44476592 |
| 166 | 11 pairs of ribs (HP:0000878) | 1.44235268 |
| 167 | Esophageal varix (HP:0002040) | 1.44135586 |
| 168 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.44100615 |
| 169 | Skin ulcer (HP:0200042) | 1.42569449 |
| 170 | Abnormality of the peritoneum (HP:0002585) | 1.42419543 |
| 171 | Osteolytic defects of the hand bones (HP:0009699) | 1.42247530 |
| 172 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.42247530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.41313557 |
| 2 | IRAK3 | 3.38350523 |
| 3 | VRK2 | 3.30543483 |
| 4 | BUB1 | 3.26818629 |
| 5 | SMG1 | 3.14944868 |
| 6 | PKN2 | 2.86725337 |
| 7 | TESK2 | 2.79480510 |
| 8 | TRIB3 | 2.68177121 |
| 9 | ERN1 | 2.59545157 |
| 10 | WEE1 | 2.36825413 |
| 11 | SCYL2 | 2.21906249 |
| 12 | TESK1 | 2.18492023 |
| 13 | PIM2 | 2.17409699 |
| 14 | RPS6KA4 | 2.15825641 |
| 15 | KDR | 2.12762832 |
| 16 | EIF2AK1 | 2.11258959 |
| 17 | NEK2 | 1.89466776 |
| 18 | LRRK2 | 1.85508858 |
| 19 | CDC7 | 1.84737711 |
| 20 | MAP3K10 | 1.83540875 |
| 21 | MAP3K11 | 1.82890131 |
| 22 | EEF2K | 1.80587348 |
| 23 | MAP4K1 | 1.79546101 |
| 24 | NEK1 | 1.78568155 |
| 25 | PRPF4B | 1.78140856 |
| 26 | PAK4 | 1.72461502 |
| 27 | STK10 | 1.59506712 |
| 28 | MAP2K3 | 1.54210811 |
| 29 | BCKDK | 1.53540729 |
| 30 | BLK | 1.52594645 |
| 31 | MAP3K8 | 1.47217804 |
| 32 | EPHA2 | 1.44863700 |
| 33 | RPS6KB2 | 1.42464435 |
| 34 | FLT3 | 1.40613416 |
| 35 | ZAP70 | 1.27380159 |
| 36 | ICK | 1.25720424 |
| 37 | BRSK2 | 1.21572739 |
| 38 | TGFBR1 | 1.19560173 |
| 39 | TBK1 | 1.18907629 |
| 40 | CDK7 | 1.15725936 |
| 41 | PASK | 1.14422637 |
| 42 | TYK2 | 1.13830537 |
| 43 | IRAK4 | 1.13458911 |
| 44 | MAP3K3 | 1.08809582 |
| 45 | AURKB | 1.06991782 |
| 46 | SIK1 | 1.06691947 |
| 47 | EIF2AK3 | 1.04919762 |
| 48 | MAPKAPK3 | 1.04042841 |
| 49 | TAOK2 | 1.03977928 |
| 50 | CDK4 | 1.00227276 |
| 51 | PLK1 | 0.98841991 |
| 52 | PTK6 | 0.98024468 |
| 53 | LIMK1 | 0.97530724 |
| 54 | GRK6 | 0.96553940 |
| 55 | STK16 | 0.96076344 |
| 56 | ILK | 0.94642241 |
| 57 | AURKA | 0.93453966 |
| 58 | TTK | 0.92814220 |
| 59 | TLK1 | 0.91703987 |
| 60 | DAPK1 | 0.89828264 |
| 61 | PIM1 | 0.89789411 |
| 62 | BTK | 0.87349399 |
| 63 | DYRK3 | 0.86486365 |
| 64 | ACVR1B | 0.85632701 |
| 65 | ARAF | 0.84954973 |
| 66 | PAK1 | 0.84840436 |
| 67 | CDK8 | 0.84237250 |
| 68 | JAK3 | 0.82035469 |
| 69 | BRSK1 | 0.75231382 |
| 70 | IRAK2 | 0.74948330 |
| 71 | ATR | 0.72316547 |
| 72 | BMX | 0.71062524 |
| 73 | NEK9 | 0.70357051 |
| 74 | CDK6 | 0.69861825 |
| 75 | CDK19 | 0.69482520 |
| 76 | MAP3K12 | 0.69104126 |
| 77 | ABL2 | 0.66150269 |
| 78 | PLK4 | 0.64433882 |
| 79 | NME1 | 0.63974779 |
| 80 | MAP3K1 | 0.63496315 |
| 81 | MAP2K2 | 0.61927213 |
| 82 | MST1R | 0.59342928 |
| 83 | TSSK6 | 0.58590788 |
| 84 | STK4 | 0.57163610 |
| 85 | MST4 | 0.57096736 |
| 86 | TAOK1 | 0.56347128 |
| 87 | VRK1 | 0.56340945 |
| 88 | BRAF | 0.54888241 |
| 89 | LMTK2 | 0.53599309 |
| 90 | FGFR4 | 0.51605458 |
| 91 | SRPK1 | 0.51409402 |
| 92 | PTK2 | 0.50194974 |
| 93 | MAP3K14 | 0.50154294 |
| 94 | RIPK4 | 0.50047370 |
| 95 | LATS2 | 0.48732289 |
| 96 | MAPKAPK2 | 0.46450189 |
| 97 | CSNK1G3 | 0.46128548 |
| 98 | PDPK1 | 0.46024091 |
| 99 | CDK12 | 0.45444964 |
| 100 | TTN | 0.44458164 |
| 101 | RIPK1 | 0.44001672 |
| 102 | KIT | 0.44001549 |
| 103 | IKBKB | 0.43684141 |
| 104 | RPS6KA5 | 0.43299478 |
| 105 | PBK | 0.42929480 |
| 106 | PRKCI | 0.41122582 |
| 107 | PRKG2 | 0.40933055 |
| 108 | MAPK11 | 0.40911028 |
| 109 | MOS | 0.40404597 |
| 110 | PAK2 | 0.40323914 |
| 111 | DAPK3 | 0.40157647 |
| 112 | CHUK | 0.38918410 |
| 113 | TAF1 | 0.38525815 |
| 114 | MARK3 | 0.38216422 |
| 115 | CSNK2A1 | 0.38076287 |
| 116 | CHEK2 | 0.37817592 |
| 117 | RAF1 | 0.35955140 |
| 118 | MAP2K6 | 0.35610787 |
| 119 | CHEK1 | 0.35560753 |
| 120 | SIK3 | 0.35478294 |
| 121 | KSR2 | 0.35289436 |
| 122 | CDK11A | 0.35230443 |
| 123 | FGFR1 | 0.34804212 |
| 124 | AKT2 | 0.33613010 |
| 125 | TEC | 0.33510909 |
| 126 | CSNK2A2 | 0.33015322 |
| 127 | CSF1R | 0.32838364 |
| 128 | MAP3K5 | 0.32535501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.94111059 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.76067485 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.40591443 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.78083793 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.41305941 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.36822535 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.21279973 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.05336582 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 1.99094539 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.97995204 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.94304292 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.79730707 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.75427396 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.67929064 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.58350552 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53953749 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.53438146 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51792238 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47187224 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47008464 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46185364 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43341501 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.34619109 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.32543170 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.31490332 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30653560 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27530479 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22851550 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21817876 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21542136 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19292895 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15629243 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15582316 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14441880 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12832779 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12447909 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11726021 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07685644 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.05964066 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01585896 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00856631 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98325648 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96596730 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95963392 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95264928 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94705565 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93712736 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.86397320 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84324405 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83616111 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83226612 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.82038575 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81844493 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77479052 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77229670 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75170848 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 0.73717614 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71938813 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71481429 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69358793 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.67264059 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66772317 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66697180 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65653921 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65071582 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63520096 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63314886 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63210771 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.62890554 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62803898 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61738847 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61356529 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60702431 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.58065365 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58050724 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.57871388 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55507112 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54896920 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53843252 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53640183 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53102450 |
| 82 | Protein export_Homo sapiens_hsa03060 | 0.52617311 |
| 83 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.52541411 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50161130 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49729311 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48918823 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48754259 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.48422753 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.47476857 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46511610 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.46493405 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46219896 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46047488 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45702777 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45475966 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43696293 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43043928 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41873752 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41051343 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40344609 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39851287 |
| 102 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38833828 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37691746 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37592820 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36812155 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.35986553 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.35963872 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35286982 |
| 109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35050420 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.34011167 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34001120 |
| 112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33703860 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.33303721 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32960515 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32717870 |
| 116 | Tuberculosis_Homo sapiens_hsa05152 | 0.32536187 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31982319 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31226218 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.31155124 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30578740 |

